Home/Contractors/Altasciences Clinical Kansas INC/contracts

Federal Contractor Profile

Altasciences Clinical Kansas INC

$12M obligated·11 awards·1 agencies·4 NAICS

Federal Contracts

Showing contracts 115 of 15 total. Sorted by action date, most recent first. Excludes $0 modifications.

DateAgencyPIIDNAICSDescriptionAmount
Sep 10, 2025Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95024F00001541715INVESTIGATIONAL AGENT SINGLE ASCENDING DOSE SAFETY, TOLERABILITY, AND PK STUDY. SEPTEMBER 3, 2024 TO MARCH 2, 2026. N01DA-23-8935$287K
May 2, 2025Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95025F00001541715INVESTIGATIONAL AGENT SINGLE ASCENDING DOSE SAFETY, TOLERABILITY, AND PK STUDY. POP: 5/2/2025 - 11/1/2026. N01DA-23-8935$1.3M
Sep 12, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95024F00001541715INVESTIGATIONAL AGENT SINGLE ASCENDING DOSE SAFETY, TOLERABILITY, AND PK STUDY. SEPTEMBER 3, 2024 TO MARCH 2, 2026. N01DA-23-8935$1.4M
Jul 31, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDAHHSN271201700056C541712IGF::OT::IGF: PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES FOR MEDICATIONS DEVELOPMENT. POP: 9/20/2017-9/19/2022. N01DA-17-8935.$146K
Jun 5, 2024Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS75F40121C00199541715DOSE-FINDING STUDY OF KRATOM ALKALOIDS PILOT$25K
Sep 22, 2023Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95023F00001541715PHARMACOKINETIC AND PHARMACODYNAMIC TRIALS FOR MEDICATION DEVELOPMENT IN SUD. TO1 PHASE 1 COCAINE DRUG INTERACTION SEPTEMBER 25, 2023 TO MARCH 24, 2025. N01DA-23-893$1.8M
Sep 30, 2021Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS75F40121C00199541715DOSE-FINDING STUDY OF KRATOM ALKALOIDS PILOT$2.3M
Sep 22, 2020Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDAHHSN271201700056C541712IGF::OT::IGF: PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES FOR MEDICATIONS DEVELOPMENT. POP: 9/20/2017-9/19/2022. N01DA-17-8935.$1.4M
Sep 19, 2019Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDAHHSN271201700056C541712IGF::OT::IGF: PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES FOR MEDICATIONS DEVELOPMENT. POP: 9/20/2017-9/19/2022. N01DA-17-8935.$1.3M
Jan 23, 2018Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCSHHSF223201510138C541690IGF::CL::IGF - PROJECT ON PHARMACOKINETICS STUDY OF OPIOID DRUG PRODUCT FOLLOWING INSUFFLATION OF MILLED DRUG PRODUCTS$67K
Sep 20, 2017Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDAHHSN271201700056C541712IGF::OT::IGF: PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES FOR MEDICATIONS DEVELOPMENT. POP: 9/20/2017-9/19/2022. N01DA-17-8935.$724K
Jun 29, 2017Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCSHHSF223201510138C541690IGF::CL::IGF - PROJECT ON PHARMACOKINETICS STUDY OF OPIOID DRUG PRODUCT FOLLOWING INSUFFLATION OF MILLED DRUG PRODUCTS$304K
Jan 31, 2017Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDAHHSN271201200018C541712IGF::OT::IGF -- OTHER FUNCTION; N01DA-12-8905; PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES FOR MEDICATIONS DEVELOPMENT$413K
Apr 8, 2016Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDAHHSN271201200018C541712IGF::OT::IGF -- OTHER FUNCTION; N01DA-12-8905; PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES FOR MEDICATIONS DEVELOPMENT$324K
Jan 11, 2016Department of Health and Human ServicesDEPT OF HHS/FOOD AND DRUG ADMINISTRATIONHHSF22301003T541990IGF::CL::IGF - PROJECT ON BIOEQUIVALENCE STUDY OF LAMOTRIGINE EXTENDED RELEASE TABLETS.$40K

Get Alerted Before Altasciences Clinical Kansas INC's Next Recompete

Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.

Start Free